Related Experiment Video
Updated: Aug 11, 2026

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
Published on: August 24, 2015
Abstract:
Riboflavin deficiency diminishes the rate of growth of spontaneous tumors in experimental animals but enhances the carcinogenicity of specific drugs such as the azo dyes, which are degraded by a microsomal hydroxylase system requiring riboflavin. Human esophageal cancer has been epidemiologically associated with riboflavin deficiency, but the precise role of riboflavin in this tumor remains to be defined. Riboflavin nutriture influences epithelial integrity, tissue flavin concentrations, rates of prostaglandin biosynthesis, and glutathione metabolism, each of which may have implications for carcinogenesis.
Insights
Riboflavin deficiency slows tumor growth in animals but increases cancer risk with certain azo dyes. Its role in human esophageal cancer is unclear, affecting epithelial integrity and metabolism.
Area of Science:
- Biochemistry
- Oncology
- Nutritional Science
Background:
- Riboflavin deficiency impacts spontaneous tumor growth in animal models.
- Certain azo dyes' carcinogenicity is enhanced by riboflavin deficiency due to altered drug metabolism.
- Epidemiological studies link human esophageal cancer to riboflavin deficiency.
Purpose of the Study:
- To define the precise role of riboflavin in human esophageal carcinogenesis.
- To investigate how riboflavin nutriture influences factors relevant to cancer development.
Main Methods:
- Review of existing literature on riboflavin, azo dyes, and carcinogenesis.
- Analysis of epidemiological data associating riboflavin deficiency with esophageal cancer.
- Examination of riboflavin's influence on cellular processes like epithelial integrity, prostaglandin biosynthesis, and glutathione metabolism.
Main Results:
- Riboflavin deficiency inhibits spontaneous tumor growth but potentiates carcinogenicity of specific agents like azo dyes.
- Azo dye metabolism via microsomal hydroxylase systems requires riboflavin.
- Riboflavin status affects epithelial integrity, tissue flavin levels, prostaglandin synthesis, and glutathione metabolism.
Conclusions:
- Riboflavin's role in human esophageal cancer requires further elucidation.
- Riboflavin nutriture influences multiple pathways potentially involved in carcinogenesis.
- Understanding riboflavin's complex effects is crucial for cancer prevention and therapy strategies.
More Related Videos
Related Concept Videos
Ribosomal RNA Synthesis
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
Riboswitches
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
Ribozymes
Ribozymes can be...
Ribozymes
Ribozymes can be...
Ribosomal RNA Synthesis
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
Antiviral Nucleoside Inhibitors

